Preterm Births and PROM Testing Market Size Set to Cross USD 362 Million with the CAGR of 7.74% by 2029 | BlueWeave Consulting

North America held the highest share in the global preterm birth and PROM testing market, due to the region's high incidence of preterm births. The increased consumption of alcohol and illegal drugs in the United States has also contributed to the rise in premature births. Non-profit organizations in the United States and Canada have initiated awareness campaigns and programs aimed at addressing the challenges faced by premature babies and their families. In Asia Pacific, the market is expected to record significant growth, driven by the large population of China and India and the rising number of preterm births in developing countries of the region. The market growth is also attributed to rapid technological advancements, well-established healthcare infrastructure, and an increase in awareness campaigns and non-profit organizations supporting preterm infants and their families.


New Delhi, April 19, 2023 (GLOBE NEWSWIRE) -- Global preterm births and PROM testing market is flourishing because of increasing awareness about and technological advancements in point-of care and PROM testing for the management of preterm and low-weight births.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global preterm births and PROM testing market size at USD 198.54 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global preterm births and PROM testing market size to grow at a significant CAGR of 7.74% reaching a value of USD 362.41 million by 2029. Major growth factors of global preterm births and PROM testing market include increasing incidence of preterm and low-weight births worldwide, rapid continuous development of point-of-care diagnostic techniques and growing technological advancements in PROM testing equipment. Greater awareness of the availability of testing for preterm births and PROM is also a significant driver. Also, the market growth is driven by the rise in premature births and associated child mortality rates. People are increasingly seeking testing services at diagnostic labs and healthcare facilities, particularly in emerging regions. Diagnostic centers are becoming increasingly popular due to their reliability, affordability, rapid results, and accurate diagnosis, making them a preferred choice. As a result, the market is expected to grow significantly in the coming years. However, lack of awareness and economic constraints in under-developed countries is anticipated to restrain the growth of overall market.


Global Preterm Births and PROM Testing Market – Overview

Premature Rupture of Membrane, commonly known as PROM, is a prevalent complication in pregnancy and a significant cause of preterm births. Preterm birth testing and PROM testing encompass the examination of symptoms, such as vaginal spotting, cramps, contractions, pelvic pressure, vaginal discharge, and fluid leakage, by gynecologists to identify preterm labor. Expectant management and hospitalization are some of the management and treatment strategies for PROM. In rare cases, the membrane may self-seal without intervention, stopping fluid leakage. To determine changes in the cervix and record contractions, healthcare professionals frequently perform pelvic exams over a few hours. Traditional techniques, such as fetal fibronectin (fFN) test, pelvic examination, blood test, ultrasound, and sterile speculum inspection (pooling), are highly accurate in detecting preterm labor. Timely detection of preterm labor reduces the risk of infant morbidity and mortality, decreases the hospital stay for high-risk patients, and eliminates unnecessary medical expenses.

Sample Request @ https://www.blueweaveconsulting.com/report/preterm-births-and-prom-testing-market/report-sample

Impact of COVID-19 on Global Preterm Births and PROM Testing Market

COVID-19 had a detrimental impact on the global preterm birth and PROM testing market. The pandemic resulted in the redirection of healthcare resources and attention towards COVID-19, potentially leading to a decline in preterm birth and PROM testing. The global economic downturn caused by the pandemic may also result in reduced healthcare spending, which could further impact the market's growth. Moreover, the pandemic has led to disruptions in supply chains and manufacturing operations, which may cause delays in the production and delivery of diagnostic equipment and testing supplies. However, the increasing focus on public health and the importance of early detection of diseases may provide opportunities for the market to rebound in the post-pandemic period. In response to the pandemic, healthcare facilities and diagnostic labs have implemented new safety protocols to reduce the risk of transmission, including the use of telemedicine and remote testing options. These adaptations may help to maintain access to preterm birth and PROM testing while reducing the risk of exposure to COVID-19.

Please Visit the Press Release: https://www.blueweaveconsulting.com/press-release/global-preterm-births-and-prom-testing-market-size-set-to-cross-usd-362-million-by-2029

Global Preterm Births and PROM Testing Market – By End User

Based on end user, global preterm births and PROM testing market is bifurcated into Hospitals and Clinical Laboratories segments. The clinical laboratories segment holds a higher share in the global preterm births and PROM testing market due to the increasing demand for accurate and reliable diagnostic testing and clinical laboratories offer a wide range of diagnostic tests and services for preterm births and PROM testing, including fetal fibronectin (fFN) testing, pelvic examination, blood tests, and sterile speculum inspection (pooling). Also, clinical laboratories provide fast and efficient testing services, allowing for timely diagnosis and treatment, thereby reducing the risk of preterm births and improving neonatal outcomes coupled with the increasing prevalence of preterm births and associated complications worldwide is boosting the demand for clinical laboratory services for preterm births and PROM testing.

Competitive Landscape

Major players operating global preterm births and PROM testing market include Hologic, Inc, Abbott, Sera Prognostics Inc., Cooper Surgical Inc., IQ Products, Qiagen N.V., Biosynex, LifeCell International Pvt. Ltd., Clinical Innovations, Inc., NX Prenatal, Inc., Medixibiochemica, Medtronic, Fisher & Paykel Healthcare Limited, FUJIFILM Holdings Corporation, Nonin, Getinge AB, General Electric, and Koninklijke Philips N.V. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Don’t miss the business opportunity in the Global Preterm Births and PROM Testing Market. Consult our analysts to gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Preterm Births and PROM Testing Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Preterm Births and PROM Testing Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.



Recent Developments

  • In April 2021 - Hologic Inc. launched Hologic Preterm Birth Risk Test, a new test is designed to help identify women who are at increased risk of delivering prematurely. Hologic Preterm Birth Risk Test uses a combination of fetal fibronectin (fFN) testing and cervical length measurement to predict the likelihood of preterm birth.

Scope of the Report

AttributesDetails
Years ConsideredHistorical Data – 2019–2022
Base Year – 2022
Estimated Year – 2023
Forecast Period – 2023–2029
Facts CoveredRevenue in USD Million
Market CoverageNorth America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA)
Product/ Service SegmentationTest Type, End Use, Region
Key PlayersHologic, Inc, Abbott, Sera Prognostics Inc., Cooper Surgical Inc., IQ Products, Qiagen N.V., Biosynex, LifeCell International Pvt. Ltd., Clinical Innovations, Inc., NX Prenatal, Inc., Medixibiochemica, Medtronic, Fisher & Paykel Healthcare Limited, FUJIFILM Holdings Corporation, Nonin, Getinge AB, General Electric, Koninklijke Philips N.V.

By Test Type

  • Pelvic Exam
  • Ultrasound
  • Biochemical Markers
  • Uterine Monitoring
  • Nitazine Test
  • Ferning Test
  • Pooling

By End User

  • Hospitals
  • Clinical Laboratories

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa



Please Find Below Some Related Topics:

About Us 

BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing qualitative and quantitative data to boost the performance of your business solutions. BlueWeave has built its reputation by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.

Contact Us:

BlueWeave Consulting & Research Pvt. Ltd

+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662

info@blueweaveconsulting.com
https://www.blueweaveconsulting.com/

https://www.linkedin.com/company/blueweaveconsulting/